Dylan Coté

Dylan Coté is a health economics professional with over 10 years of experience specializing in the value demonstration of health technologies. They have contributed to the Australian Pharmaceutical Benefits Advisory Committee (PBAC) and Medicare Services Advisory Committee (MSAC), helping to expand access to effective therapies for thousands of Australian patients annually. Dylan has authored over 50 health technology assessments and has developed expertise in valuing pharmaceuticals, devices, and diagnostics. Their educational background includes a Master of Science in International Health Policy from the London School of Economics and a Bachelor of Arts in Public Health Studies and Spanish from The Johns Hopkins University.